Management of cannabis use during pregnancy: An assessment of healthcare professionals' practices

Pharmacoepidemiology and Drug Safety

Volumn 20, Issue 5, 2011, Pages 464-473

  Gérardin, Marie ^a   Victorri Vigneau, Caroline ^a,b   Louvigné, Cécile ^a   Rivoal, Marion ^c   Jolliet, Pascale ^a,b  

^a NANTES UNIVERSITY HOSPITAL   (France)

^b Universite de Nantes   (France)

^c Midwives School   (France)

Author keywords

Cannabis; Healthcare professionals; Pregnancy

Indexed keywords

CANNABIS; ILLICIT DRUG;

ARTICLE; CHILDBIRTH; CLINICAL PRACTICE; CONSULTATION; DRUG ABUSE; GENERAL PRACTITIONER; GYNECOLOGY; HEALTH CARE PERSONNEL; HUMAN; PREGNANCY; PRENATAL CARE; PRIORITY JOURNAL; QUESTIONNAIRE; RISK ASSESSMENT; STATISTICAL SIGNIFICANCE;

ATTITUDE OF HEALTH PERSONNEL; FEMALE; FRANCE; GYNECOLOGY; HEALTH CARE SURVEYS; HUMANS; MARIJUANA ABUSE; MATERNAL HEALTH SERVICES; MIDWIFERY; OBSTETRICS; PREGNANCY; PREGNANCY COMPLICATIONS; QUESTIONNAIRES; TIME FACTORS;

EID: 79955146906     PISSN: 10538569     EISSN: 10991557     Source Type: Journal    
DOI: 10.1002/pds.2095     Document Type: Article

References (32)

1. Davitian C, Uzan M, Tigaizin A, Ducarme G, Dauphin H, Poncelet C. Maternal cannabis use and intra-uterine growth restriction. Gynecol Obstet Fertil 2006; 34(7-8): 632-637.
2. Westfall RE, Janssen PA, Lucas P, Capler R. Survey of medicinal cannabis use among childbearing women: patterns of its use in pregnancy and retroactive self-assessment of its efficacy against 'morning sickness'. Complement Ther Clin Pract 2006; 12(1): 27-33.
3. Schempf AH, Strobino DM. Illicit drug use and adverse birth outcomes: is it drugs or context? J Urban Health 2008; 85(6): 858-873.
4. Williams LJ, Correa A, Rasmussen S. Maternal lifestyle factors and risk for ventricular septal defects. Birth Defects Res A Clin Mol Teratol 2004; 70(2): 59-64.
5. Greenland S, Staisch KJ, Brown N, Gross SJ. The effects of marijuana use during pregnancy: I. A preliminary epidemiologic study. Am J Obstet Gynecol 1982; 143(4): 408-413.
6. Blackard C, Tennes K. Human placental transfer of cannabinoids. N Engl J Med 1984; 311: 797.
7. Park B, Gibbons HM, Mitchell MD, Glass M. Identification of the CB1 cannabinoid receptor and fatty acid amide hydrolase (FAAH) in the human placenta. Placenta 2003; 24(10): 990-995.
8. Fried PA, Watkinson B, Willan A. Marijuana use during pregnancy and decreased length of gestation. Am J Obstet Gynecol 1984; 150(1): 23-27.
9. Hatch EE, Bracken MB. Effect of marijuana use in pregnancy on fetal growth. Am J Epidemiol 1986; 124(6): 986-993.
10. Cornelius MD, Goldschmidt L, Day NL, Larkby C. Alcohol tobacco and marijuana use among pregnant teenagers: 6-year follow-up of offspring growth effects. Neurotoxicol Teratol 2002; 24(6): 703-710.
11. Fergusson DM, Horwood LJ, Northstone K. ALSPAC Study Team. Avon Longitudinal Study of Pregnancy and Childhood. Maternal use of cannabis and pregnancy outcome. BJOG 2002; 109(1): 21-27.
12. Zuckerman B, Frank DA, Hingson R, et al. Effects of maternal marijuana and cocaine use on fetal growth. N Engl J Med 1989; 320(12): 762-768.
13. Robison LL, Buckley JD, Daigle AE, et al. Maternal drug use and risk of childhood nonlymphoblastic leukemia among offspring: an epidemiologic investigation implicating marijuana (a report from the Childrens Cancer Study Group). Cancer. 1989; 63(10): 1904-1911.
14. Trivers KF, Mertens AC, Ross JA, Steinbuch M, Olshan AF, Robison LL. Children's Cancer Group. Parental marijuana use and risk of childhood acute myeloid leukaemia: a report from the Children's Cancer Group (United States and Canada). Paediatr Perinat Epidemiol 2006; 20(2): 110-118.
15. Richardson GA, Day NL, Goldschmidt L. Prenatal alcohol, marijuana, and tobacco use: infant mental and motor development. Neurotoxicol Teratol 1995; 17(4): 479-487.
16. Day NL, Richardson GA, Goldschmidt L, et al. Effect of prenatal marijuana exposure on the cognitive development of offspring at age three. Neurotoxicol Teratol 1994; 16(2): 169-175.
17. Goldschmidt L, Day NL, Richardson GA. Effects of prenatal marijuana exposure on child behavior problems at age 10. Neurotoxicol Teratol 2000; 22(3): 325-336.
18. Richardson GA, Ryan C, Willford J, Day NL, Goldschmidt L. Prenatal alcohol and marijuana exposure: effects on neuropsychological outcomes at 10 years. Neurotoxicol Teratol 2002; 24(3): 309-320.
19. Fried PA, Watkinson B. Differential effects on facets of attention in adolescents prenatally exposed to cigarettes and marihuana. Neurotoxicol Teratol 2001; 23(5): 421-430.
20. Gray KA, Day NL, Leech S, Richardson GA. Prenatal marijuana exposure: effect on child depressive symptoms at ten years of age. Neurotoxicol Teratol 2005; 27(3): 439-448.
21. Goldschmidt L, Richardson GA, Cornelius MD, Day NL. Prenatal marijuana and alcohol exposure and academic achievement at age 10. Neurotoxicol Teratol 2004; 26(4): 521-532.
22. Porath AJ, Fried PA. Effects of prenatal cigarette and marijuana exposure on drug use among offspring. Neurotoxicol Teratol 2005; 27(2): 267-277.
23. Smith AM, Fried PA, Hogan MJ, Cameron I. Effects of prenatal marijuana on response inhibition: an fMRI study of young adults. Neurotoxicol Teratol 2004; 26(4): 533-542.
24. Smith AM, Fried PA, Hogan MJ, Cameron I. Effects of prenatal marijuana on visuospatial working memory: an fMRI study in young adults. Neurotoxicol Teratol. 2006; 28(2): 286-295.
25. Mission Interministérielle de Lutte contre la Drogue et la Toxicomanie. Plan gouvernemental de lutte contre les drogues et les toxicomanies 2008/2011. Available at
26. Glover M, Paynter J, Bullen C, Kristensen K. Supporting pregnant women to quit smoking: postal survey of New Zealand general practitioners and midwives' smoking cessation knowledge and practices. N Z Med J 2008; 121(1270): 53-65.
27. Abatemarco DJ, Steinberg MB, Delnevo CD. Midwives' knowledge, perceptions, beliefs, and practice supports regarding tobacco dependence treatment. J Midwifery Womens Health 2007; 52(5): 451-457.
28. Haute Autorité de Santé. Recommandations professionnelles Préparation à la naissance et à la parentalité (PNP). November 2005.
29. Gregory KD, Johnson CT, Johnson TRB, Entmann SS. The content of prenatal care. Update 2005. Womens Health Issues 2006; 16(4): 198-215. Review.
30. Dumas A, Lejeune C, Simmat-Durand L, Crenn-Hébert C, Mandelbrot L. Pregnancy and psychoactives substances: prevalence study based on the declared consumption. J Gynecol Obstet Biol Reprod (Paris) 2008; 37(8): 770-778.
31. El Marroun, Tiemeier H, Jaddoe H, et al. emotional and social determinants of cannabis use in early pregnancy: the Generation R study. Drug Alcohol Depend 2008; 98(3): 218-226.
32. Beck F, Legleye S, Spilka S, et al. Les niveaux d'usage des drogues en France en 2005, exploitation des données du Baromètre santé 2005. Tendances 2006; 48: 1-6.